BioNeutra Global Corporation
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more
BioNeutra Global Corporation (BGACF) - Total Assets
Latest total assets as of September 2024: $13.57 Million USD
Based on the latest financial reports, BioNeutra Global Corporation (BGACF) holds total assets worth $13.57 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioNeutra Global Corporation - Total Assets Trend (1997–2023)
This chart illustrates how BioNeutra Global Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioNeutra Global Corporation - Asset Composition Analysis
Current Asset Composition (December 2023)
BioNeutra Global Corporation's total assets of $13.57 Million consist of 44.2% current assets and 55.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.0% |
| Accounts Receivable | $1.18 Million | 7.5% |
| Inventory | $3.29 Million | 20.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $320.31K | 2.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1997–2023)
This chart illustrates how BioNeutra Global Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioNeutra Global Corporation's current assets represent 44.2% of total assets in 2023, an increase from 28.6% in 1997.
- Cash Position: Cash and equivalents constituted 12.0% of total assets in 2023, down from 14.3% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1997.
- Asset Diversification: The largest asset category is inventory at 20.9% of total assets.
BioNeutra Global Corporation Competitors by Total Assets
Key competitors of BioNeutra Global Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
B&G Foods Inc
NYSE:BGS
|
USA | $2.94 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥17.90 Billion |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
China | CN¥7.01 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
BioNeutra Global Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BioNeutra Global Corporation generates 0.72x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioNeutra Global Corporation is currently not profitable relative to its asset base.
BioNeutra Global Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.35 | 0.39 | 0.92 |
| Quick Ratio | 0.17 | 0.18 | 0.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-9.93 Million | $ -10.13 Million | $ -1.89 Million |
BioNeutra Global Corporation - Advanced Valuation Insights
This section examines the relationship between BioNeutra Global Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -20.3% |
| Total Assets | $15.77 Million |
| Market Capitalization | $260.11K USD |
Valuation Analysis
Below Book Valuation: The market values BioNeutra Global Corporation's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BioNeutra Global Corporation's assets decreased by 20.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BioNeutra Global Corporation (1997–2023)
The table below shows the annual total assets of BioNeutra Global Corporation from 1997 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $15.77 Million | -20.30% |
| 2022-12-31 | $19.78 Million | -6.18% |
| 2021-12-31 | $21.08 Million | -10.95% |
| 2020-12-31 | $23.68 Million | -30.41% |
| 2019-12-31 | $34.02 Million | -14.91% |
| 2018-12-31 | $39.99 Million | +29.11% |
| 2017-12-31 | $30.97 Million | -15.38% |
| 2016-12-31 | $36.60 Million | +36.67% |
| 2015-12-31 | $26.78 Million | +93.71% |
| 2014-12-31 | $13.82 Million | +123.91% |
| 2013-12-31 | $6.17 Million | +2026.68% |
| 2012-12-31 | $290.31K | -35.44% |
| 2011-12-31 | $449.64K | -13.79% |
| 2010-12-31 | $521.57K | -33.16% |
| 2009-12-31 | $780.35K | -1.64% |
| 2008-12-31 | $793.33K | -60.84% |
| 2007-12-31 | $2.03 Million | -40.98% |
| 2006-12-31 | $3.43 Million | -46.39% |
| 2005-12-31 | $6.40 Million | +7.35% |
| 2004-12-31 | $5.97 Million | +79.38% |
| 2003-12-31 | $3.33 Million | -19.23% |
| 2002-12-31 | $4.12 Million | +33.12% |
| 2001-12-31 | $3.09 Million | +44.59% |
| 2000-12-31 | $2.14 Million | -2.78% |
| 1999-12-31 | $2.20 Million | +144.44% |
| 1998-12-31 | $900.00K | +28.57% |
| 1997-12-31 | $700.00K | -- |